263 related articles for article (PubMed ID: 27245865)
21. Unique microRNA profile in Dupuytren's contracture supports deregulation of β-catenin pathway.
Mosakhani N; Guled M; Lahti L; Borze I; Forsman M; Pääkkönen V; Ryhänen J; Knuutila S
Mod Pathol; 2010 Nov; 23(11):1544-52. PubMed ID: 20676061
[TBL] [Abstract][Full Text] [Related]
22. Wnt signaling and Dupuytren's disease.
Dolmans GH; Werker PM; Hennies HC; Furniss D; Festen EA; Franke L; Becker K; van der Vlies P; Wolffenbuttel BH; Tinschert S; Toliat MR; Nothnagel M; Franke A; Klopp N; Wichmann HE; Nürnberg P; Giele H; Ophoff RA; Wijmenga C; ; ; ;
N Engl J Med; 2011 Jul; 365(4):307-17. PubMed ID: 21732829
[TBL] [Abstract][Full Text] [Related]
23. Increased CCT-eta expression is a marker of latent and active disease and a modulator of fibroblast contractility in Dupuytren's contracture.
Satish L; O'Gorman DB; Johnson S; Raykha C; Gan BS; Wang JH; Kathju S
Cell Stress Chaperones; 2013 Jul; 18(4):397-404. PubMed ID: 23292503
[TBL] [Abstract][Full Text] [Related]
24. Adipose-derived stem cells inhibit the contractile myofibroblast in Dupuytren's disease.
Verhoekx JSN; Mudera V; Walbeehm ET; Hovius SER
Plast Reconstr Surg; 2013 Nov; 132(5):1139-1148. PubMed ID: 23924646
[TBL] [Abstract][Full Text] [Related]
25. Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic target.
Verjee LS; Verhoekx JS; Chan JK; Krausgruber T; Nicolaidou V; Izadi D; Davidson D; Feldmann M; Midwood KS; Nanchahal J
Proc Natl Acad Sci U S A; 2013 Mar; 110(10):E928-37. PubMed ID: 23431165
[TBL] [Abstract][Full Text] [Related]
26. DNA copy number variations at chromosome 7p14.1 and chromosome 14q11.2 are associated with dupuytren's disease: potential role for MMP and Wnt signaling pathway.
Shih B; Tassabehji M; Watson JS; Bayat A
Plast Reconstr Surg; 2012 Apr; 129(4):921-932. PubMed ID: 22183494
[TBL] [Abstract][Full Text] [Related]
27. The biochemistry of Dupuytren's disease.
Badalamente MA; Hurst LC
Hand Clin; 1999 Feb; 15(1):35-42, v-vi. PubMed ID: 10050240
[TBL] [Abstract][Full Text] [Related]
28. Wnt expression is not correlated with beta-catenin dysregulation in Dupuytren's Disease.
O'Gorman DB; Wu Y; Seney S; Zhu RD; Gan BS
J Negat Results Biomed; 2006 Aug; 5():13. PubMed ID: 16942611
[TBL] [Abstract][Full Text] [Related]
29. An insight into Dupuytren's contracture.
Murrell GA
Ann R Coll Surg Engl; 1992 May; 74(3):156-60; discussion 161. PubMed ID: 1616255
[TBL] [Abstract][Full Text] [Related]
30. Enhanced Dupuytren's disease fibroblast populated collagen lattice contraction is independent of endogenous active TGF-beta2.
Tse R; Howard J; Wu Y; Gan BS
BMC Musculoskelet Disord; 2004 Nov; 5(1):41. PubMed ID: 15541177
[TBL] [Abstract][Full Text] [Related]
31. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.
Ulrich D; Hrynyschyn K; Pallua N
Plast Reconstr Surg; 2003 Oct; 112(5):1279-86. PubMed ID: 14504511
[TBL] [Abstract][Full Text] [Related]
32. Expression of a novel gene, MafB, in Dupuytren's disease.
Lee LC; Zhang AY; Chong AK; Pham H; Longaker MT; Chang J
J Hand Surg Am; 2006 Feb; 31(2):211-8. PubMed ID: 16473681
[TBL] [Abstract][Full Text] [Related]
33. Cellular structure and biology of Dupuytren's disease.
Tomasek JJ; Vaughan MB; Haaksma CJ
Hand Clin; 1999 Feb; 15(1):21-34. PubMed ID: 10050239
[TBL] [Abstract][Full Text] [Related]
34. Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture.
Qian A; Meals RA; Rajfer J; Gonzalez-Cadavid NF
Urology; 2004 Aug; 64(2):399-404. PubMed ID: 15302515
[TBL] [Abstract][Full Text] [Related]
35. [Genetic aspect of Dupuytren's diseases].
Bobiński R; Olczyk K; Wisowski G; Janusz W
Wiad Lek; 2004; 57(1-2):59-62. PubMed ID: 15181751
[TBL] [Abstract][Full Text] [Related]
36. Major Genetic Risk Factors for Dupuytren's Disease Are Inherited From Neandertals.
Ågren R; Patil S; Zhou X; ; Sahlholm K; Pääbo S; Zeberg H
Mol Biol Evol; 2023 Jun; 40(6):. PubMed ID: 37315093
[TBL] [Abstract][Full Text] [Related]
37. Fibroblasts from phenotypically normal palmar fascia exhibit molecular profiles highly similar to fibroblasts from active disease in Dupuytren's Contracture.
Satish L; LaFramboise WA; Johnson S; Vi L; Njarlangattil A; Raykha C; Krill-Burger JM; Gallo PH; O'Gorman DB; Gan BS; Baratz ME; Ehrlich GD; Kathju S
BMC Med Genomics; 2012 May; 5():15. PubMed ID: 22559715
[TBL] [Abstract][Full Text] [Related]
38. Involvement of pro-inflammatory cytokines and growth factors in the pathogenesis of Dupuytren's contracture: a novel target for a possible future therapeutic strategy?
Bianchi E; Taurone S; Bardella L; Signore A; Pompili E; Sessa V; Chiappetta C; Fumagalli L; Di Gioia C; Pastore FS; Scarpa S; Artico M
Clin Sci (Lond); 2015 Oct; 129(8):711-20. PubMed ID: 26201022
[TBL] [Abstract][Full Text] [Related]
39. Feedback inhibition of high TGF-beta1 concentrations on myofibroblast induction and contraction by Dupuytren's fibroblasts.
Wong M; Mudera V
J Hand Surg Br; 2006 Oct; 31(5):473-83. PubMed ID: 16875762
[TBL] [Abstract][Full Text] [Related]
40. Prostaglandins influence myofibroblast contractility in Dupuytren's disease.
Badalamente MA; Hurst LC; Sampson SP
J Hand Surg Am; 1988 Nov; 13(6):867-71. PubMed ID: 3225412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
